| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/10/2023 | 3.32% | BMO Capital | $24 → $28 | Maintains | Market Perform |
| 11/10/2023 | 21.77% | Goldman Sachs | $25 → $33 | Maintains | Buy |
| 11/10/2023 | 10.7% | Morgan Stanley | $25 → $30 | Maintains | Overweight |
| 11/10/2023 | 7.01% | Raymond James | $24 → $29 | Maintains | Outperform |
| 11/10/2023 | 29.15% | Needham | $25 → $35 | Maintains | Buy |
| 09/18/2023 | -7.75% | Morgan Stanley | → $25 | Reinstates | → Overweight |
| 08/21/2023 | 3.32% | JMP Securities | → $28 | Reiterates | Market Outperform → Market Outperform |
| 08/10/2023 | -22.51% | Citigroup | $22 → $21 | Maintains | Neutral |
| 08/10/2023 | -18.82% | BMO Capital | $23 → $22 | Maintains | Market Perform |
| 08/10/2023 | -7.75% | Needham | → $25 | Reiterates | Buy → Buy |
| 07/21/2023 | -18.82% | Citigroup | $23 → $22 | Maintains | Neutral |
| 05/11/2023 | -15.13% | BMO Capital | $21 → $23 | Maintains | Market Perform |
| 05/11/2023 | 3.32% | JMP Securities | → $28 | Reiterates | Market Outperform → Market Outperform |
| 05/11/2023 | -7.75% | Needham | → $25 | Reiterates | Buy → Buy |
| 05/11/2023 | -11.44% | Raymond James | $22 → $24 | Maintains | Outperform |
| 05/11/2023 | -26.2% | Jefferies | $18 → $20 | Maintains | Hold |
| 03/09/2023 | 3.32% | JMP Securities | → $28 | Reiterates | → Market Outperform |
| 03/09/2023 | -11.44% | Goldman Sachs | $21 → $24 | Maintains | Buy |
| 03/09/2023 | -29.89% | BMO Capital | $16 → $19 | Maintains | Market Perform |
| 03/09/2023 | -18.82% | Raymond James | $19 → $22 | Maintains | Outperform |
| 03/09/2023 | -26.2% | B of A Securities | $16 → $20 | Upgrades | Underperform → Neutral |
| 03/09/2023 | -7.75% | Needham | $19 → $25 | Maintains | Buy |
| 02/09/2023 | -29.89% | Raymond James | → $19 | Initiates Coverage On | → Outperform |
| 01/05/2023 | -44.65% | Jefferies | $13.5 → $15 | Downgrades | Buy → Hold |
| 12/19/2022 | -55.72% | Morgan Stanley | $10 → $12 | Maintains | Underweight |
| 11/10/2022 | -44.65% | BMO Capital | $14 → $15 | Maintains | Market Perform |
| 10/21/2022 | -26.2% | Goldman Sachs | → $20 | Initiates Coverage On | → Buy |
| 09/01/2022 | -44.65% | Citigroup | → $15 | Initiates Coverage On | → Neutral |
| 07/14/2022 | -63.1% | Morgan Stanley | $12 → $10 | Maintains | Underweight |
| 05/23/2022 | -50.18% | Jefferies | $14.5 → $13.5 | Maintains | Buy |
| 05/11/2022 | -55.72% | Morgan Stanley | $13 → $12 | Maintains | Underweight |
| 03/10/2022 | 3.32% | JMP Securities | $36 → $28 | Maintains | Market Outperform |
| 03/10/2022 | -29.89% | Needham | $30 → $19 | Maintains | Buy |
| 02/01/2022 | -44.65% | BMO Capital | → $15 | Initiates Coverage On | → Market Perform |
| 10/04/2021 | -26.2% | B of A Securities | $24 → $20 | Downgrades | Neutral → Underperform |
| 08/25/2021 | -0.37% | Berenberg | → $27 | Initiates Coverage On | → Buy |
| 08/24/2021 | -0.37% | Berenberg | → $27 | Initiates Coverage On | → Buy |
| 06/03/2021 | -33.58% | Goldman Sachs | $24 → $18 | Downgrades | Neutral → Sell |
| 05/14/2021 | -40.96% | Morgan Stanley | $18 → $16 | Maintains | Underweight |
| 04/07/2021 | -33.58% | Morgan Stanley | → $18 | Downgrades | Equal-Weight → Underweight |
| 11/17/2020 | 10.7% | Needham | → $30 | Initiates Coverage On | → Buy |
| 11/12/2020 | -22.51% | Morgan Stanley | $23 → $21 | Maintains | Equal-Weight |
| 08/24/2020 | 25.46% | Jefferies | → $34 | Initiates Coverage On | → Buy |
| 08/24/2020 | — | William Blair | Initiates Coverage On | → Outperform | |
| 08/24/2020 | -15.13% | Morgan Stanley | → $23 | Initiates Coverage On | → Equal-Weight |
| 08/24/2020 | 14.39% | Stifel | → $31 | Initiates Coverage On | → Buy |
| 08/24/2020 | 18.08% | B of A Securities | → $32 | Initiates Coverage On | → Neutral |
| 08/24/2020 | -4.06% | Goldman Sachs | → $26 | Initiates Coverage On | → Neutral |
| 08/24/2020 | 7.01% | Citigroup | → $29 | Initiates Coverage On | → Neutral |
What is the target price for Vertex (VERX)?
The latest price target for Vertex (NASDAQ: VERX) was reported by BMO Capital on November 10, 2023. The analyst firm set a price target for $28.00 expecting VERX to rise to within 12 months (a possible 3.32% upside). 25 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Vertex (VERX)?
The latest analyst rating for Vertex (NASDAQ: VERX) was provided by BMO Capital, and Vertex maintained their market perform rating.
When is the next analyst rating going to be posted or updated for Vertex (VERX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vertex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vertex was filed on November 10, 2023 so you should expect the next rating to be made available sometime around November 10, 2024.
Is the Analyst Rating Vertex (VERX) correct?
While ratings are subjective and will change, the latest Vertex (VERX) rating was a maintained with a price target of $24.00 to $28.00. The current price Vertex (VERX) is trading at is $27.10, which is within the analyst's predicted range.
